456 related articles for article (PubMed ID: 24988203)
1. Effects of Difaprost® on voiding dysfunction, histology and inflammation markers in patients with benign prostatic hyperplasia who are candidates for surgical treatment.
Suardi N; Gandaglia G; Nini A; Montorsi F; Pellucchi F; Agostini A; Rigatti P
Minerva Urol Nefrol; 2014 Jun; 66(2):119-25. PubMed ID: 24988203
[TBL] [Abstract][Full Text] [Related]
2. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
[TBL] [Abstract][Full Text] [Related]
3. Multicentre study on the efficacy and tolerability of an extract of Serenoa repens in patients with chronic benign prostate conditions associated with inflammation.
Giulianelli R; Pecoraro S; Sepe G; Leonardi R; Gentile BC; Albanesi L; Brunori S; Mavilla L; Pisanti F; Giannella R; Morello P; Tuzzolo D; Coscione M; Galasso F; D'Angelo T; Ferravante P; Morelli E; Miragliuolo A;
Arch Ital Urol Androl; 2012 Jun; 84(2):94-8. PubMed ID: 22908779
[TBL] [Abstract][Full Text] [Related]
4. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
[TBL] [Abstract][Full Text] [Related]
5. Effects of Serenoa repens Alcohol Extract on Benign Prostate Hyperplasia.
Saidi S; Stavridis S; Stankov O; Dohcev S; Panov S
Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2017 Sep; 38(2):123-129. PubMed ID: 28991765
[TBL] [Abstract][Full Text] [Related]
6. Does the addition of Serenoa repens to tamsulosin improve its therapeutical efficacy in benign prostatic hyperplasia?
Argirović A; Argirović D
Vojnosanit Pregl; 2013 Dec; 70(12):1091-6. PubMed ID: 24450252
[TBL] [Abstract][Full Text] [Related]
7. Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome.
Sökeland J
BJU Int; 2000 Sep; 86(4):439-42. PubMed ID: 10971268
[TBL] [Abstract][Full Text] [Related]
8. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
9. Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project.
Bertaccini A; Giampaoli M; Cividini R; Gattoni GL; Sanseverino R; Realfonso T; Napodano G; Fandella A; Guidoni E; Prezioso D; Galasso R; Cicalese C; Scattoni V; Armenio A; Conti G; Corinti M; Spasciani R; Liguori G; Lampropoulou N; Martorana G
Arch Ital Urol Androl; 2012 Sep; 84(3):117-22. PubMed ID: 23210402
[TBL] [Abstract][Full Text] [Related]
10. Association between asymptomatic inflammatory prostatitis NIH category IV and prostatic calcification in patients with obstructive benign prostatic hyperplasia.
Engelhardt PF; Seklehner S; Brustmann H; Riedl CR; Lusuardi L
Minerva Urol Nefrol; 2016 Jun; 68(3):242-9. PubMed ID: 26013949
[TBL] [Abstract][Full Text] [Related]
11. Role of inflammation in benign prostatic hyperplasia development among Han Chinese: A population-based and single-institutional analysis.
Hu J; Zhang L; Zou L; Hu M; Fan J; Cai Y; Xu G; Fang J; Ding Q; Jiang H
Int J Urol; 2015 Dec; 22(12):1138-42. PubMed ID: 26311564
[TBL] [Abstract][Full Text] [Related]
12. [Prostamol-Uno treatment in patients with prostatic adenoma and chronic non-infectious prostatitis].
Trapeznikova MF; Dutov VV; Dolgovq AG; Urenkov SB
Urologiia; 2008; (5):39-42. PubMed ID: 19069494
[TBL] [Abstract][Full Text] [Related]
13. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
Debruyne F; Koch G; Boyle P; Da Silva FC; Gillenwater JG; Hamdy FC; Perrin P; Teillac P; Vela-Navarrete R; Raynaud JP
Eur Urol; 2002 May; 41(5):497-506; discussion 506-7. PubMed ID: 12074791
[TBL] [Abstract][Full Text] [Related]
14. [Correlation of histological prostatitis with PSA, prostate volume, PSAD, IPSS, Qmax and PVR in BPH patients].
Zhang HT; Xu Y; Chang JW; Zhang ZH; Liu RL; Ma BJ
Zhonghua Nan Ke Xue; 2012 Mar; 18(3):208-11. PubMed ID: 22474983
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of histological prostatitis in men with benign prostatic hyperplasia or adenocarcinoma of the prostate presenting without urinary retention.
Edlin RS; Heyns CF; Van Vuuren SP; Zarrabi AD
S Afr J Surg; 2012 Nov; 50(4):127-30. PubMed ID: 23217554
[TBL] [Abstract][Full Text] [Related]
16. Patients With Prostatic Inflammation Undergoing Transurethral Prostatic Resection Have a Larger Early Improvement of Storage Symptoms.
De Nunzio C; Brassetti A; Gacci M; Finazzi Agrò E; Carini M; Presicce F; Tubaro A
Urology; 2015 Aug; 86(2):359-65. PubMed ID: 26194294
[TBL] [Abstract][Full Text] [Related]
17. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
Jhang JF; Jiang YH; Kuo HC
Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
[TBL] [Abstract][Full Text] [Related]
18. An improvement in sexual function is related to better quality of life, regardless of urinary function improvement: results from the IDIProst® Gold Study.
Cai T; Morgia G; Carrieri G; Terrone C; Imbimbo C; Verze P; Mirone V;
Arch Ital Urol Androl; 2013 Dec; 85(4):184-9. PubMed ID: 24399119
[TBL] [Abstract][Full Text] [Related]
19. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.
Safarinejad MR
J Herb Pharmacother; 2005; 5(4):1-11. PubMed ID: 16635963
[TBL] [Abstract][Full Text] [Related]
20. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
Klippel KF; Hiltl DM; Schipp B
Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
